D'Arma A - Search Results

1

Identification of modified dynamic gait index cutoff scores for assessing fall risk in people with Parkinson disease, stroke and multiple sclerosis.

Torchio A, Corrini C, Anastasi D, Parelli R, Meotti M, Spedicato A, Groppo E, D'Arma A, Grosso C, Montesano A, Cattaneo D, Gervasoni E. Torchio A, et al. Gait Posture. 2022 Jan;91:1-6. doi: 10.1016/j.gaitpost.2021.09.201. Epub 2021 Oct 2. Gait Posture. 2022. PMID: 34628216

2

Social Mind and Long-Lasting Disease: Focus on Affective and Cognitive Theory of Mind in Multiple Sclerosis.

Isernia S, Baglio F, d'Arma A, Groppo E, Marchetti A, Massaro D. Isernia S, et al. Front Psychol. 2019 Feb 7;10:218. doi: 10.3389/fpsyg.2019.00218. eCollection 2019. Front Psychol. 2019. PMID: 30792684 Free PMC article.

3

Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study.

La Mantia L, Benedetti MD, Sant M, d'Arma A, Di Tella S, Lillini R, Mendozzi L, Marangi A, Turatti M, Caputo D, Rovaris M. La Mantia L, et al. Neurol Sci. 2021 Dec;42(12):5157-5163. doi: 10.1007/s10072-021-05216-z. Epub 2021 Mar 31. Neurol Sci. 2021. PMID: 33791892

4

Managing chronic disease in the COVID-19 pandemic: an e-learning application to promote a healthy lifestyle for persons with multiple sclerosis.

d'Arma A, Rossi V, Pugnetti L, Grosso C, Sinatra M, Dos Santos R, Di Giusto G, Mendozzi L. d'Arma A, et al. Psychol Health Med. 2022 Feb;27(2):428-435. doi: 10.1080/13548506.2021.1939072. Epub 2021 Jun 15. Psychol Health Med. 2022. PMID: 34130565

5

Minimal clinically important difference of modified dynamic gait index in people with neurological disorders.

Corrini C, Torchio A, Anastasi D, Parelli R, Meotti M, Spedicato A, Groppo E, D'Arma A, Grosso C, Montesano A, Cattaneo D, Gervasoni E. Corrini C, et al. Gait Posture. 2021 Oct;90:210-214. doi: 10.1016/j.gaitpost.2021.08.024. Epub 2021 Aug 28. Gait Posture. 2021. PMID: 34509972 Clinical Trial.

6

Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis.

Chisari CG, Grimaldi LM, Salemi G, Ragonese P, Iaffaldano P, Bonavita S, Sparaco M, Rovaris M, D'Arma A, Lugaresi A, Ferrò MT, Grossi P, Di Sapio A, Cocco E, Granella F, Curti E, Lepore V, Trojano M, Patti F; Italian MS Register Study Group. Chisari CG, et al. J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1297-1303. doi: 10.1136/jnnp-2020-323472. Epub 2020 Oct 14. J Neurol Neurosurg Psychiatry. 2020. PMID: 33055141

7

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.

Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C, Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34753829 Free PMC article.

8

Signs and symptoms of COVID-19 in patients with multiple sclerosis.

Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.

9

Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis.

Barone M, Mendozzi L, D'Amico F, Saresella M, Rampelli S, Piancone F, La Rosa F, Marventano I, Clerici M, d'Arma A, Pugnetti L, Rossi V, Candela M, Brigidi P, Turroni S. Barone M, et al. Int J Mol Sci. 2021 Jul 2;22(13):7173. doi: 10.3390/ijms22137173. Int J Mol Sci. 2021. PMID: 34281224 Free PMC article. Clinical Trial.

10

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.

Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Mult Scler. 2022 Jun;28(7):1034-1040. doi: 10.1177/13524585211035318. Epub 2021 Jul 30. Mult Scler. 2022. PMID: 34328824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters